Wu, Xiaochu
Zhang, Tianyao
Tu, Yanhao
Deng, Xueling
Sigen, A
Li, Yuxiao
Jing, Xiaofan
Wei, Lixuan
Huang, Ning
Cheng, Ying
Deng, Linghui
Jia, Shuli
Li, Jun
Jiang, Ning
Dong, Birong
Funding for this research was provided by:
Project of Max Cynader Academy of Brain Workstation, West China Hospital, Sichuan University (HXYS19005)
National Key Technologies R&D Program provided by Ministry of Science and Technology of the People’s Republic of China (Project Grant # 2022YFC3602300, Sub-project Grant # 2022YFC3602303)
Article History
Received: 23 June 2023
Accepted: 13 September 2023
First Online: 28 September 2023
Declarations
:
: The authors declare no competing interests.
: Research ethics approval. The MINE trial was approved by the Medical Ethics Committee of the West China Hospital of Sichuan University (Reference Number: 2020–287). It was registered with the China Clinical Trial Registration Center (Registration number: ChiCTR2000035012). All methods were performed in accordance with the relevant guidelines and regulations.
: (1) Contact potential participants by phone, ask if they are interested in participating in this study, and invite those who agree to ethical communication. (2) Introduce the project in person, and explain the main contents of ethical, informed consent, such as purpose, steps, risks, and benefits. (3) Again, ask the participant if they agree to participate in our study. If the subject agrees to participate, both parties (the participant and the researcher) will sign the ethical, informed consent; otherwise, all subsequent procedures will be stopped. (4) To manage ethical, informed consent, each participant and the researcher must keep a copy, and the original version shall be kept for future reference.
: The project leaders of each subcenter will obtain written authorization from the NCRCG for subject recruitment, informed consent signing, and data collection and use, etc. Informed consent will be obtained from all subjects and/or their legal guardian(s).
: Not applicable.